When scientific ambition meets the strength of partnership, new possibilities begin to take shape.
India Global Forum (IGF), in partnership with
@nanopore (Oxford Nanopore Technologies), convened the 'From National Genomics to Global Leadership: Accelerating the UK-India Genomics Partnership' roundtable in New Delhi.
The roundtable followed the signing of a new letter of intent between Oxford Nanopore Technologies and CSIR-IGIB, reflecting the growing momentum in UK–India genomics collaboration.
The closed-door discussion was co-chaired by
@FCDO_Ben (Ben Mellor), Deputy High Commissioner,
@UKinIndia (British High Commission), New Delhi, and Sarah Cooper, Minister Counsellor & Director, Development, Climate, Science & Technology, British High Commission, New Delhi, and curated by William Carne, Director – Programmes, IGF. It built on the growing UK–India relationship across science, technology and health, including frameworks such as Vision 2035, the Technology Security Initiative (TSI) and the UK–India Free Trade Agreement (CETA).
@dasgobardhan (Prof. Gobardhan Das), Member,
@NITIAayog (NITI Aayog), shared his reflections on the opportunity for the UK and India to bring their respective expertise together in genomics and the wider bioeconomy.
The roundtable brought together senior leaders from India's scientific and research ecosystem, including the Office of the Principal Scientific Adviser (PSA), Tata Institute for Genetics and Society (TIGS), BRIC-National Institute of Biomedical Genomics (BRIC-NIBMG), Centre for Brain Research (CBR), Indian Institute of Science (IISc), Regional Centre for Biotechnology (RCB), CSIR-Institute of Genomics and Integrative Biology (CSIR-IGIB), CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB), BRIC-Institute of Life Sciences (BRIC-ILS), and Translational Health Science and Technology Institute (THSTI), among others.
The conversation marked the start of a new chapter for both countries with regard to shared scientific ambition and complementary strengths. India's Genome India programme has laid an important foundation, and the next phase offers an opportunity to deepen the scientific and clinical value this partnership can generate. Drawing on the combined experience the UK and India bring to population-scale sequencing, secure data infrastructure and the translation of genomic research into clinical care, important healthcare outcomes can be achieved in both countries.
#IndiaGlobalForum #OxfordNanoporeTechnologies #NationalGenomics #Partnership #Roundtable